ABTI OTC
Alterola Biotech, Inc.
1W: +0.0%
1M: +0.0%
3M: -96.1%
YTD: -96.1%
1Y: +0.0%
3Y: -99.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.3M
52W Range0.000199999995-0.2
Volume20
Avg Volume162
Beta1.52
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODavid John Hitchcock
Employees1
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2010-05-05
Websitealterola-abti.com
47 Hamilton Square
Birkenhead, MR CH41 5AR
GB
Birkenhead, MR CH41 5AR
GB
44 1516 019 477
About Alterola Biotech, Inc.
Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bright Green Corp | 0 | — | 2022-10-03 |